DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+2.41%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$198M
AUM Growth
+$3.87M
(+2%)
Cap. Flow
+$4.66M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
42.17%
Holding
97
New
13
Increased
28
Reduced
18
Closed
14
Top Buys
| 1 |
Lifecore Biomedical
LFCR
|
$1.87M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$1.52M |
| 3 |
Advanced Micro Devices
AMD
|
$1.45M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$1.42M |
| 5 |
Baidu
BIDU
|
$1.03M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$4.96M |
| 2 |
Alibaba
BABA
|
$4.59M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$2.33M |
| 4 |
Turning Point Brands
TPB
|
$2.3M |
| 5 |
B
Barrick Mining Corporation
B
|
$1.39M |
Sector Composition
| 1 | Healthcare | 36.9% |
| 2 | Technology | 19.76% |
| 3 | Communication Services | 8.6% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Financials | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Royalty Pharma
RPRX
$15.8B
| – | – |
-15,000
| Closed | -$424K |
|
77
AT&T
T
$211B
| – | – |
-10,200
| Closed | -$224K |
|
78
Vanguard S&P 500 ETF
VOO
$726B
| – | – |
0
| – | – |
|
79
Arq
ARQ
$311M
| – | – |
-73,000
| Closed | -$429K |
|
|
RVNC
80
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-19,417
| Closed | -$101K |
|